Engineering of CD19-Specific Chimeric Antigen Receptor T Cells with the Integrin CD103 Results in Augmented Therapeutic Efficacy Against Human Lymphoma in a Preclinical Model

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Sun Hongxing; He Shan; Meng Lijun; Wang Ying; Zhang Hanghang; Liu Yongnian; Wang Jian; Tao Min; Barta Stefan Klaus; Al-Saleem Essel D.; Fung Henry C.; Issa Jean-Pierre; Zheng Leizhen; Zhang Yi;

  展开▼
• 作者单位

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Soochow Univ Inst Pediat Children Hosp Suzhou Peoples R China;

  Soochow Univ Affiliated Hosp 1 Dept Oncol Suzhou Peoples R China;

  Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;

  Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;

  Fox Chase Canc Ctr Dept Hematol Oncol 7701 Burholme Ave Philadelphia PA 19111 USA;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  Jiao Tong Univ Sch Med Xin Hua Hosp Dept Oncol Shanghai Peoples R China;

  Temple Univ Fels Inst Canc Res &

  Mol Biol Philadelphia PA 19122 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词